OPKO Health Statistics
Total Valuation
OPKO Health has a market cap or net worth of $1.14 billion. The enterprise value is $1.22 billion.
Important Dates
The next estimated earnings date is Tuesday, May 6, 2025, after market close.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OPKO Health has 671.55 million shares outstanding. The number of shares has decreased by -7.68% in one year.
| Current Share Class | 671.55M |
| Shares Outstanding | 671.55M |
| Shares Change (YoY) | -7.68% |
| Shares Change (QoQ) | -4.66% |
| Owned by Insiders (%) | 51.91% |
| Owned by Institutions (%) | 24.32% |
| Float | 254.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.69 |
| Forward PS | 1.68 |
| PB Ratio | 0.86 |
| P/TBV Ratio | 46.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.43, with a Debt / Equity ratio of 0.37.
| Current Ratio | 3.43 |
| Quick Ratio | 2.87 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.76 |
Financial Efficiency
Return on equity (ROE) is -3.86% and return on invested capital (ROIC) is -9.54%.
| Return on Equity (ROE) | -3.86% |
| Return on Assets (ROA) | -8.12% |
| Return on Invested Capital (ROIC) | -9.54% |
| Return on Capital Employed (ROCE) | -13.63% |
| Revenue Per Employee | $237,952 |
| Profits Per Employee | -$17,759 |
| Employee Count | 2,997 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 8.86 |
Taxes
In the past 12 months, OPKO Health has paid $42.84 million in taxes.
| Income Tax | 42.84M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +58.88% in the last 52 weeks. The beta is 1.71, so OPKO Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.71 |
| 52-Week Price Change | +58.88% |
| 50-Day Moving Average | 1.68 |
| 200-Day Moving Average | 1.53 |
| Relative Strength Index (RSI) | 44.12 |
| Average Volume (20 Days) | 7,904,572 |
Short Selling Information
The latest short interest is 88.63 million, so 13.20% of the outstanding shares have been sold short.
| Short Interest | 88.63M |
| Short Previous Month | 88.64M |
| Short % of Shares Out | 13.20% |
| Short % of Float | 34.87% |
| Short Ratio (days to cover) | 13.28 |
Income Statement
In the last 12 months, OPKO Health had revenue of $713.14 million and -$53.22 million in losses. Loss per share was -$0.08.
| Revenue | 713.14M |
| Gross Profit | 113.30M |
| Operating Income | -273.56M |
| Pretax Income | -244.67M |
| Net Income | -53.22M |
| EBITDA | -175.38M |
| EBIT | -273.56M |
| Loss Per Share | -$0.08 |
Full Income StatementBalance Sheet
The company has $426.58 million in cash and $504.44 million in debt, giving a net cash position of -$77.86 million or -$0.12 per share.
| Cash & Cash Equivalents | 426.58M |
| Total Debt | 504.44M |
| Net Cash | -77.86M |
| Net Cash Per Share | -$0.12 |
| Equity (Book Value) | 1.37B |
| Book Value Per Share | 2.03 |
| Working Capital | 468.99M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$183.49 million and capital expenditures -$25.01 million, giving a free cash flow of -$208.50 million.
| Operating Cash Flow | -183.49M |
| Capital Expenditures | -25.01M |
| Free Cash Flow | -208.50M |
| FCF Per Share | -$0.31 |
Full Cash Flow StatementMargins
Gross margin is 15.89%, with operating and profit margins of -38.36% and -7.46%.
| Gross Margin | 15.89% |
| Operating Margin | -38.36% |
| Pretax Margin | -1.46% |
| Profit Margin | -7.46% |
| EBITDA Margin | -24.59% |
| EBIT Margin | -38.36% |
| FCF Margin | n/a |
Dividends & Yields
OPKO Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 7.68% |
| Shareholder Yield | 7.68% |
| Earnings Yield | -4.65% |
| FCF Yield | -18.21% |
Dividend DetailsAnalyst Forecast
The average price target for OPKO Health is $2.75, which is 61.77% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.75 |
| Price Target Difference | 61.77% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 7.04% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OPKO Health has an Altman Z-Score of -0.48 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.48 |
| Piotroski F-Score | 1 |